Estrella Immunopharma (ESLA) Q1 2025 Earnings

25MarConfirmed
Q4 2024
Q1 2025
-0.12
0.21
0.55
0.88

Details

Expected EPS
-0.12
Actual EPS
-0.12
Surprise EPS
0
Surprise Percent
+0%

Description

Estrella Immunopharma (ESLA) has reported earnings of -0.12 per share for Q1 2025.

0 Comments

Share your thoughts